Somatostatin analogs in acromegaly

被引：218
作者：
Freda, PU [1 ]
机构：
[1] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2002年 / 87卷 / 07期
关键词：
D O I：
10.1210/jc.87.7.3013
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3013 / 3018
页数：6
相关论文
共 82 条
[1]   The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly [J].
AlMaskari, M ;
Gebbie, J ;
KendallTaylor, P .
CLINICAL ENDOCRINOLOGY, 1996, 45 (04) :415-421
[2]   Cardiac effects of slow-release lanreotide, a slow-release somatostatin analog, in acromegalic patients [J].
Baldelli, R ;
Ferretti, E ;
Jaffrain-Rea, ML ;
Iacobellis, G ;
Minniti, G ;
Caracciolo, B ;
Moroni, C ;
Cassone, R ;
Gulino, A ;
Tamburrano, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (02) :527-532
[3]   Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg) [J].
Baldelli, R ;
Colao, A ;
Razzore, P ;
Jaffrain-Rea, ML ;
Marzullo, P ;
Ciccarelli, E ;
Ferretti, E ;
Ferone, D ;
Gaia, D ;
Camanni, F ;
Lombardi, G ;
Tamburrano, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (11) :4099-4103
[4]   PREOPERATIVE TREATMENT OF ACROMEGALY WITH LONG-ACTING SOMATOSTATIN ANALOG SMS-201-995 - SHRINKAGE OF INVASIVE PITUITARY MACROADENOMAS AND IMPROVED SURGICAL REMISSION RATE [J].
BARKAN, AL ;
LLOYD, RV ;
CHANDLER, WF ;
HATFIELD, MK ;
GEBARSKI, SS ;
KELCH, RP ;
BEITINS, IZ .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1988, 67 (05) :1040-1048
[5]   TREATMENT OF RESISTANT ACROMEGALY WITH A LONG-ACTING SOMATOSTATIN ANALOG (SMS 201-995) [J].
BARNARD, LB ;
GRANTHAM, WG ;
LAMBERTON, P ;
ODORISIO, TM ;
JACKSON, IMD .
ANNALS OF INTERNAL MEDICINE, 1986, 105 (06) :856-861
[6]   DOES TREATMENT OF ACROMEGALY AFFECT LIFE EXPECTANCY [J].
BATES, AS ;
VANTHOFF, W ;
JONES, JM ;
CLAYTON, RN .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (01) :1-5
[7]  
BAUER W, 1982, LIFE SCI, V31, P1133, DOI 10.1016/0024-3205(82)90087-X
[8]   Direct postoperative and follow-up results of transsphenoidal surgery in 19 acromegalic patients pretreated with octreotide compared to those in untreated matched controls [J].
Biermasz, NR ;
van Dulken, H ;
Roelfsema, F .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (10) :3551-3555
[9]   RADIOIMMUNOASSAY FOR INSULIN-LIKE GROWTH FACTOR-I - SOLUTIONS TO SOME POTENTIAL PROBLEMS AND PITFALLS [J].
BREIER, BH ;
GALLAHER, BW ;
GLUCKMAN, PD .
JOURNAL OF ENDOCRINOLOGY, 1991, 128 (03) :347-357
[10]   Results of a two-year treatment with slow release lanreotide in acromegaly [J].
Cannavò, S ;
Squadrito, S ;
Curtò, L ;
Almoto, B ;
Vieni, A ;
Trimarchi, F .
HORMONE AND METABOLIC RESEARCH, 2000, 32 (06) :224-229
123456789